(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HYDEAL CYST

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

HYDEAL CYST

ST13

US500000079310437

Class

5, 10

Filing

79310437

Registration

7077390

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

10/09/2023

Trademark type

Word

Nice classes

5, 10

Filing date

10/28/2020

Registration date

06/13/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/13/2023

Last transaction

06/13/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

09

Owner location

IT

Examiner

BELLOTTI, CHRISTINA L

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

FIDIA FARMACEUTICI S.p.A.

Representatives

Andrew N. Fredbeck Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for use in treating gynecological and urological diseases and disorders; pharmaceutical preparations for treating ailments caused by radiation or chemotherapy; medical preparations for use in treating gynecological and urological diseases and disorders; medical preparations for treating ailments caused by radiation or chemotherapy; medicinal preparations for use in treating gynecological and urological diseases and disorders; medicinal preparations for treating ailments caused by radiation or chemotherapy; pharmaceutical substances for use in treating gynecological and urological diseases and disorders; medicated food supplements

Class 10

syringes for injections; apparatus for irrigation of liquids for medical use; syringes and cannulas for medical use

Publications

History of USPTO decisions and trademark events.

41 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/09/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/14/2023

FIMP

FINAL DISPOSITION PROCESSED

09/14/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/13/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/13/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

06/13/2023

GPNX

NOTIFICATION PROCESSED BY IB

03/29/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/28/2023

PUBO

PUBLISHED FOR OPPOSITION

03/28/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/08/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/08/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/08/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/21/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/18/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/17/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

02/17/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

10/31/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/12/2022

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

10/12/2022

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/26/2022

GNFR

FINAL REFUSAL E-MAILED

08/26/2022

CNFR

FINAL REFUSAL WRITTEN

08/26/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/03/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/02/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/02/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/02/2022

GNRT

NON-FINAL ACTION E-MAILED

02/02/2022

CNRT

NON-FINAL ACTION WRITTEN

02/02/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/01/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/01/2021

RFNT

REFUSAL PROCESSED BY IB

06/27/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/01/2021

RFRR

REFUSAL PROCESSED BY MPU

06/01/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/27/2021

CNRT

NON-FINAL ACTION WRITTEN

05/26/2021

MAFR

APPLICATION FILING RECEIPT MAILED

05/18/2021

DOCK

ASSIGNED TO EXAMINER

05/14/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/14/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

05/13/2021

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

05/08/2021

Continuous trademark protection

Get notified about every new filing that threatens HYDEAL CYST or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.